Alan J. Main - Feb 28, 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
EVP, Innov & Chem Sciences
Signature
/s/ Alan J. Main, Ph.D.
Stock symbol
LXRX
Transactions as of
Feb 28, 2023
Transactions value $
-$45,453
Form type
4
Date filed
3/1/2023, 03:53 PM
Previous filing
Feb 13, 2023
Next filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +23.3K +13.27% 199K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +8.98K +4.51% 208K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +25.7K +12.35% 234K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Tax liability -$45.5K -20.9K -8.97% $2.17 213K Feb 28, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -23.3K -100% 0 Feb 28, 2023 Common Stock 23.3K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -8.98K -50% 8.98K Feb 28, 2023 Common Stock 8.98K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -25.7K -33.33% 51.3K Feb 28, 2023 Common Stock 25.7K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.